A recent report by Meticulous Research®, a leading global market research company, has forecasted significant growth in the single-use bioreactors market. According to the report titled 'Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (MAb, Vaccine), Research], End User - Global Forecast to 2030,' the market is expected to reach $10.3 billion by 2030, growing at a CAGR of 15.8%.

The growth is driven by factors such as the increasing adoption of disposable technologies in the pharmaceutical and biotechnology sectors, expansion of biopharmaceutical manufacturing capacities, rising pharmaceutical R&D expenditures, a growing acceptance of biosimilars, and the increasing prevalence of chronic diseases.

Market Segmentation and Key Insights
The global single-use bioreactors market is segmented based on product, type, cell type, application, end user, and geography.

Download Free Report Sample Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5005

• By Product: The market is divided into single-use bioreactor systems, media bags (2D, 3D, linear), filtration assemblies, and others. In 2023, the single-use bioreactor systems segment is expected to hold the largest market share due to benefits such as reduced cleaning requirements, smaller footprints, lower capital investments, greater flexibility, and minimized risk of cross-contamination.

• By Type: The stirred-tank bioreactors segment is anticipated to dominate the market in 2023, driven by its preference for CHO cell lines, suspension culture, and large-volume bio-production with fewer challenges than traditional designs.

• By Cell Type: Mammalian cells are expected to lead the market share in 2023, attributed to their crucial role in commercial and research bioproduction, particularly in developing complex biomolecules like monoclonal antibodies and therapeutic proteins.

• By Application: The commercial bio-production segment is projected to have the largest market share in 2023, driven by the increasing prevalence of chronic diseases, the rising demand for biopharmaceuticals, and regulatory reforms favoring biosimilars.

• By End User: Contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) are expected to witness the highest CAGR during the forecast period. The growth in this segment is driven by the outsourcing strategies of pharmaceutical and biopharmaceutical companies, and the expansion strategies of key players.

Geographical Insights
Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Europe is expected to account for the largest market share in 2023, due to factors such as increased drug sales, government and regulatory support for biopharmaceuticals, and the expansion of manufacturing capacities by various companies.

Quick Buy – Single-use Bioreactors Market- Global Opportunity Analysis And Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/67912642

Key Market Players
The report profiles several leading companies in the single-use bioreactors market, including Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.), CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research